The 80k cap is for phase 1 trials. the OSA trial is phase 1b/2b, will this cost anything additional? I would expect some additional R&D cost supporting the trial. Keep in mind IHL spent 361K in R&D last quarter without running any clinical trials.
IHL Price at posting:
6.1¢ Sentiment: None Disclosure: Not Held